Parnassus Investments’s GenMark Diagnostics, Inc GNMK Stock Holding History

Parnassus Investments’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-191,048	Closed	-$1.5M	–	94
2015 Q3	$1.5M	Sell	191,048 -323,452	-63%	-$2.99M	0.01%	89
2015 Q2	$4.66M	Sell	514,500 -605,016	-54%	-$6.1M	0.03%	84
2015 Q1	$14.5M	Sell	1,119,516 -280,484	-20%	-$3.67M	0.1%	73
2014 Q4	$19.1M	Buy	1,400,000 +28,171	+2%	+$315K	0.14%	70
2014 Q3	$12.3M	Sell	1,371,829 -746,298	-35%	-$8.03M	0.11%	77
2014 Q2	$28.7M	Buy	+2,118,127	New	+$22.1M	0.25%	59

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parnassus Investments's GNMK Position: Q4 2015 in Review

Parnassus Investments sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2015, closing a stake of 191,048 shares — an estimated $1.5M sold.

Parnassus Investments first reported a position in GNMK in Q2 2014 and held it in 6 quarters. The position peaked at $28.7M in Q2 2014. 88 funds tracked by Wall St. Rank hold GNMK as of Q4 2015.

Parnassus Investments reported no remaining GenMark Diagnostics, Inc position as of Q4 2015 after selling out during the quarter.
Parnassus Investments sold 191,048 GenMark Diagnostics, Inc shares in Q4 2015, an estimated $1.5M.
Parnassus Investments first reported a position in GenMark Diagnostics, Inc in Q2 2014 and held it in 6 quarters.
Parnassus Investments's GenMark Diagnostics, Inc position peaked at $28.7M in Q2 2014.
88 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2015.

Based on Parnassus Investments's 13F filing for Q4 2015, filed 12 Feb 2016.